First hepatitis B 'functional cure' treatment approved
Published
FDA approved GSK's Hibsago, a weekly injection taken for up to 24 weeks along with standard antiviral pills. In trials, about 20% of patients kept the virus undetectable after stopping all treatment. It's for adults without cirrhosis whose infection is already controlled.
Source: HCPLive
This is a plain-language summary. Read the original source for full details.